Dr. Elizabeth R. Stone, MD

Dr. Stone practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Stone's NPI, 1497715957, was assigned on March 27, 2006. Dr. Stone graduated from University of Miami, Miller School of Medicine in 1995. Dr. Stone holds Florida license ME0080833.

Dr. Stone's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Stone's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Stone is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Stone to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stone practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Stone's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Stone is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Stone's licenses on file in 2 states: Florida and District of Columbia.

Dmand AI lists breast cancer and lung cancer among the conditions Dr. Stone treats.

CMS data shows 461 Medicare services from Dr. Stone across 4 procedure codes in 2024, for 208 Medicare patients. Medicare paid $38,217 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 208 Medicare patients who saw Dr. Stone in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have cancer, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stone's median patient age at 66, with 95% women.

In 2024, Dr. Stone wrote 614 Medicare Part D claims for 201 patients. 94% of them were for generic drugs. CMS names the drug for 527 of them, across 6 drugs with 11 or more claims each, at $175,811 in total drug cost. In 2023, CMS named 599 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Stone for performance year 2024, reported through an alternative payment model (APM). Dr. Stone accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stone as offering telehealth.

Dmand AI links 6 papers to Dr. Stone, published from 2017 to 2022. 2020 was the busiest year, with 2. The most frequent topics are Breast Neoplasms and Carcinoma, Lobular. Dr. Stone's most frequent co-authors are Zeina Ahmad Nahleh, MD, Thomas Abraham Samuel, MD and Diana Saravia, MD.

Dmand AI links Dr. Stone to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 157 general payments to Dr. Stone from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Incyte Corporation paid the most, $331.

Dmand AI lists 1 award for Dr. Stone, most recently CMS Stage 1 EHR in 2013.

Dr. Stone graduated from University of Miami, Miller School of Medicine in 1995.

Dr. Stone is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.